Home >> Research Area >>GPCR/G protein>>Adrenergic Receptor>> (R)-(+)-m-Nitrobiphenyline oxalate

(R)-(+)-m-Nitrobiphenyline oxalate

CAS# 945618-97-3

(R)-(+)-m-Nitrobiphenyline oxalate

2D Structure

Catalog No. BCC7525----Order now to get a substantial discount!

Product Name & Size Price Stock
(R)-(+)-m-Nitrobiphenyline oxalate: 5mg $115 In Stock
(R)-(+)-m-Nitrobiphenyline oxalate: 10mg Please Inquire In Stock
(R)-(+)-m-Nitrobiphenyline oxalate: 20mg Please Inquire Please Inquire
(R)-(+)-m-Nitrobiphenyline oxalate: 50mg Please Inquire Please Inquire
(R)-(+)-m-Nitrobiphenyline oxalate: 100mg Please Inquire Please Inquire
(R)-(+)-m-Nitrobiphenyline oxalate: 200mg Please Inquire Please Inquire
(R)-(+)-m-Nitrobiphenyline oxalate: 500mg Please Inquire Please Inquire
(R)-(+)-m-Nitrobiphenyline oxalate: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of (R)-(+)-m-Nitrobiphenyline oxalate

3D structure

Package In Stock

(R)-(+)-m-Nitrobiphenyline oxalate

Number of papers citing our products

Chemical Properties of (R)-(+)-m-Nitrobiphenyline oxalate

Cas No. 945618-97-3 SDF Download SDF
PubChem ID 11361607 Appearance Powder
Formula C19H19N3O7 M.Wt 401.38
Type of Compound N/A Storage Desiccate at -20°C
Solubility Soluble in DMSO > 10 mM
Chemical Name 2-[1-[2-(3-nitrophenyl)phenoxy]ethyl]-4,5-dihydro-1H-imidazole;oxalic acid
SMILES CC(C1=NCCN1)OC2=CC=CC=C2C3=CC(=CC=C3)[N+](=O)[O-].C(=O)(C(=O)O)O
Standard InChIKey QEAVQZOJQONCSF-UHFFFAOYSA-N
Standard InChI InChI=1S/C17H17N3O3.C2H2O4/c1-12(17-18-9-10-19-17)23-16-8-3-2-7-15(16)13-5-4-6-14(11-13)20(21)22;3-1(4)2(5)6/h2-8,11-12H,9-10H2,1H3,(H,18,19);(H,3,4)(H,5,6)
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of (R)-(+)-m-Nitrobiphenyline oxalate

Descriptionα2C-adrenoceptor agonist that potently inhibits cAMP accumulation in CHO cells (EC50 = 38 nM). Behaves as an antagonist at α2A and α2B adrenoceptors (pKb values are 7.11 and 6.07 respectively).

(R)-(+)-m-Nitrobiphenyline oxalate Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

(R)-(+)-m-Nitrobiphenyline oxalate Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of (R)-(+)-m-Nitrobiphenyline oxalate

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.4914 mL 12.457 mL 24.914 mL 49.8281 mL 62.2851 mL
5 mM 0.4983 mL 2.4914 mL 4.9828 mL 9.9656 mL 12.457 mL
10 mM 0.2491 mL 1.2457 mL 2.4914 mL 4.9828 mL 6.2285 mL
50 mM 0.0498 mL 0.2491 mL 0.4983 mL 0.9966 mL 1.2457 mL
100 mM 0.0249 mL 0.1246 mL 0.2491 mL 0.4983 mL 0.6229 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on (R)-(+)-m-Nitrobiphenyline oxalate

Vasoactivity and Vasoconstriction Changes in Cattle Related to Time off Toxic Endophyte-Infected Tall Fescue.[Pubmed:27669299]

Toxins (Basel). 2016 Sep 22;8(10). pii: toxins8100271.

Previous research has indicated that serotonergic and alpha-adrenergic receptors in peripheral vasculature are affected by exposure of cattle grazing toxic endophyte-infected (E+; Epichloe coenophialia) tall fescue (Lolium arundinaceum). The objective of this experiment was to determine the period of time necessary for the vascular effects of ergot alkaloids to subside. Two experiments were conducted to investigate changes in vascular contractile response and vasoconstriction over time relative to removal from an ergot alkaloid-containing E+ tall fescue pasture. In Experiment 1, lateral saphenous vein biopsies were conducted on 21 predominantly Angus steers (357 +/- 3 kg body weight) at 0 (n = 6), 7 (n = 6), 14 (n = 5), or 28 days (n = 4) after removal from grazing pasture (3.0 ha; endpoint ergovaline + ergovalinine = 1.35 mg/kg DM) for 126 days. In Experiment 2, lateral saphenous veins were biopsied from 24 Angus-cross steers (361 +/- 4 kg body weight) at 0, 21, 42, and 63 days (n = 6 per time point) following removal from grazing tall fescue pastures (3.0 ha; first 88 days endpoint ergovaline + ergovalinine = 0.15 mg/kg DM; last 18 days endpoint ergovaline + ergovalinine = 0.57 mg/kg DM) for 106 total days. Six steers (370 +/- 18 kg body weight) off of bermudagrass pasture for the same time interval were also biopsied on Day 0 and Day 63 (n = 3 per time point). Additionally, in Experiment 2, cross-sectional ultrasound scans of caudal artery at the fourth coccygeal vertebra were taken on Days 0, 8, 15, 21, 29, 36, 42, and 45 to determine mean artery luminal area to evaluate vasoconstriction. In both experiments, steers were removed from pasture and housed in a dry lot and fed a corn silage diet for the duration of biopsies and ultrasound scans. Biopsied vessels used to evaluate vasoactivity were cleaned, incubated in a multimyograph, and exposed to increasing concentrations of 4-Bromo-3,6-dimethoxybenzocyclobuten-1-yl) methylamine hydrobromide (TCB2; 5HT2A agonist), guanfacine (GF; alpha2A-adrenergic agonist), and (R)-(+)-m-Nitrobiphenyline oxalate (NBP; alpha2C-adrenergic agonist) in both experiments and ergovaline (ERV) and ergotamine (ERT) in Experiments 1 and 2, respectively. In Experiment 1, days off pasture x agonist concentration was not significant (p > 0.1) for all four compounds tested. In Experiment 2, GF, NBP, TCB2 and ERT were significant for days off pasture x agonist concentration interaction (p < 0.02) and vasoactivity increased over time. Vasoactivity to agonists was reduced (p < 0.05) when steers were initially removed from E+ tall fescue pasture compared to bermudagrass, but did not differ by Day 63 for any variable. Luminal areas of caudal arteries in steers grazed on E+ tall fescue relaxed and were similar to steers that had grazed bermudagrass for 36 days on non-toxic diet (p = 0.15). These data demonstrate changes in peripheral vasoactivity and recovery from vasoconstriction occur beyond five weeks off toxic pasture and 5HT2A receptors appear to be more dramatically affected in the lateral saphenous vein by grazing E+ tall fescue pasture than adrenergic receptors.

Keywords:

(R)-(+)-m-Nitrobiphenyline oxalate,945618-97-3,Natural Products,Adrenergic Receptor, buy (R)-(+)-m-Nitrobiphenyline oxalate , (R)-(+)-m-Nitrobiphenyline oxalate supplier , purchase (R)-(+)-m-Nitrobiphenyline oxalate , (R)-(+)-m-Nitrobiphenyline oxalate cost , (R)-(+)-m-Nitrobiphenyline oxalate manufacturer , order (R)-(+)-m-Nitrobiphenyline oxalate , high purity (R)-(+)-m-Nitrobiphenyline oxalate

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: